Apparent absence of aging and gender effects on serotonin 1A receptors in human neocortex and hippocampus

The effects of gender, aging and gender x age on the binding of the 5-HT1A receptor high-affinity agonist [3H]8-hydroxy-2(di-N-propylamino)tetralin ([3H]8-OH-DPAT), were evaluated and compared in tissues of human prefrontal, temporal, parietal, occipital cortex and hippocampus obtained from 21 autopsy subjects. The results revealed no variation with age or gender in either the [3H]8-OH-DPAT maximum binding capacity (Bmax) or dissociation constant (Kd) values. On the other hand, when separate correlations to subject ages were performed for men and women, aging effects on [3H]8-OH-DPAT Bmax and Kd were detected: in men, a significant age-dependent decrease in Kd values was observed in the occipital cortex; in women, the Bmax significantly decreased with aging in the parietal cortex and hippocampus, while increasing in occipito-cortical membranes. Overall, the present study reveals that, although neither gender nor aging 'per se' seem to modify the 5-HT1A receptor binding, gender may reveal region-specific aging effects, i.e. on receptor affinity in men and receptor density in women. Such findings should stimulate further investigation on the hypothesized existence of gender x age-related cross-connections between serotonergic system and hypothalamus-pituitary-gonadal circuits.

[1]  J. Glowinski,et al.  Identification of presynaptic serotonin autoreceptors using a new ligand: 3H-PAT , 1983, Nature.

[2]  B. Winblad,et al.  Effect of Age on Human Brain Serotonin (S‐1) Binding Sites , 1984, Journal of neurochemistry.

[3]  P P Humphrey,et al.  International Union of Pharmacology classification of receptors for 5-hydroxytryptamine (Serotonin). , 1994, Pharmacological reviews.

[4]  A. Hirano,et al.  Nucleus raphe dorsalis in Alzheimer's disease: Neurofibrillary tangles and loss of large neurons , 1985, Annals of neurology.

[5]  Anat Biegon,et al.  Autoradiographic analysis of age-dependent changes in serotonin 5-HT2 receptors of the human brain postmortem , 1990, Brain Research.

[6]  M. Folstein,et al.  EFFECTS OF AGE ON DOPAMINE AND SEROTONIN RECEPTORS MEASURED BY POSITRON TOMOGRAPHY IN THE LIVING HUMAN BRAIN , 1984, Science.

[7]  S. Peroutka,et al.  Pharmacological Differentiation and Characterization of 5‐HT1A, 5‐HT1B, and 5‐HT1C Binding Sites in Rat Frontal Cortex , 1986, Journal of neurochemistry.

[8]  B. Kirkpatrick,et al.  Sexual dimorphism in the brain: It's worse than you thought , 1995, Biological Psychiatry.

[9]  D. Neary,et al.  Biochemical Assessment of Serotonergic and Cholinergic Dysfunction and Cerebral Atrophy in Alzheimer's Disease , 1983, Journal of neurochemistry.

[10]  J. Barrett,et al.  Psychopathology in the aged , 1980 .

[11]  K. Lesch,et al.  Subsensitivity of the 5-hydroxytryptamine1A (5-HT1A) receptor-mediated hypothermic response to ipsapirone in unipolar depression. , 1990, Life sciences.

[12]  D. Blazer,et al.  Depression in Late Life , 1989 .

[13]  C. Tanaka,et al.  Increase in serotonin 5-HT1A receptors in prefrontal and temporal cortices of brains from patients with chronic schizophrenia. , 1991, Life sciences.

[14]  L. D. van de Kar,et al.  Neuroendocrine Pharmacology of Serotonergic (5-HT) Neurons , 1991 .

[15]  H. Ladinsky,et al.  Localization and gene expression of serotonin1A (5HT1A) receptors in human brain postmortem , 1994, Brain Research.

[16]  R. Hen,et al.  5-Hydroxytryptamine receptor subtypes in vertebrates and invertebrates , 1994, Neurochemistry International.

[17]  A. Gulati,et al.  Aging and 3H-paroxetine binding in rat brain: effect of imipramine and tetrahydroacridine. , 1993, Life sciences.

[18]  B. Bošković,et al.  THE SITE OF ACTION OF ANTIPARKINSONISM DRUGS. , 1964, International journal of neuropharmacology.

[19]  Lee N. Robins,et al.  Psychiatric Disorders in America: The Epidemiologic Catchment Area Study , 1990 .

[20]  D. Morgan The dopamine and serotonin systems during aging in human and rodent brain. A brief review , 1987, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

[21]  A. Biegon,et al.  Autoradiographic analysis of tritiated imipramine binding in the human brain post mortem: effects of suicide. , 1989, Archives of general psychiatry.

[22]  J. Palacios,et al.  Serotonin receptors in the human brain. I. Characterization and autoradiographic localization of 5-HT1A recognition sites. Apparent absence of 5-HT1B recognition sites , 1986, Brain Research.

[23]  N. Sims,et al.  Biochemical Evidence of Selective Nerve Cell Changes in the Normal Ageing Human and Rat Brain , 1983, Journal of neurochemistry.

[24]  J. Marcusson,et al.  Effect of aging in human cortical pre- and postsynaptic serotonin binding sites , 1993, Brain Research.

[25]  J. Vry,et al.  5-HT1A receptor ligands in animal models of anxiety, impulsivity and depression: Multiple mechanisms of action? , 1993, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

[26]  I. Lucki,et al.  5-Hydroxytryptamine1A receptors and behavioral responses. , 1990, Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology.

[27]  J. Bockaert,et al.  Serotonin 5-HT1 receptors mediate inhibition of cyclic AMP production in neurons. , 1986, European journal of pharmacology.

[28]  F. Artaud,et al.  Biochemical evidence for the 5-HT agonist properties of PAT (8-hydroxy-2-(di-n-propylamino)tetralin) in the rat brain. , 1984, European journal of pharmacology.

[29]  Anat Biegon,et al.  Autoradiographic analysis of serotonin 5-HT1A receptor binding in the human brain postmortem: effects of age and alcohol , 1991, Brain Research.

[30]  R. Gorski,et al.  Two sexually dimorphic cell groups in the human brain , 1989, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[31]  D. Middlemiss,et al.  Binding of the Novel Serotonin Agonist 8‐Hydroxy‐2‐(Di‐n‐Propylamino) Tetralin in Normal and Alzheimer Brain , 1986, Journal of neurochemistry.

[32]  S. Pradhan Central neurotransmitters and aging. , 1980, Life sciences.

[33]  B. Winblad,et al.  Preservation of 5-hydroxytryptamine1A receptor-G protein interactions in the cerebral cortex of patients with Alzheimer's disease , 1991, Neuroscience Letters.

[34]  H. Ladinsky,et al.  Further characterisation of [3H]8-hydroxy-2-(di-N-propylamino)tetralin binding sites in human brain postmortem , 1997, Neurochemistry International.